首页> 美国卫生研究院文献>PLoS Clinical Trials >Expansion of Cord Blood CD34+ Cells in Presence of zVADfmk and zLLYfmk Improved Their In Vitro Functionality and In Vivo Engraftment in NOD/SCID Mouse
【2h】

Expansion of Cord Blood CD34+ Cells in Presence of zVADfmk and zLLYfmk Improved Their In Vitro Functionality and In Vivo Engraftment in NOD/SCID Mouse

机译:zVADfmk和zLLYfmk存在时脐血CD34 +细胞的扩增改善了它们在NOD / SCID小鼠中的体外功能和体内移植

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCord blood (CB) is a promising source for hematopoietic stem cell transplantations. The limitation of cell dose associated with this source has prompted the ex vivo expansion of hematopoietic stem and progenitor cells (HSPCs). However, the expansion procedure is known to exhaust the stem cell pool causing cellular defects that promote apoptosis and disrupt homing to the bone marrow. The role of apoptotic machinery in the regulation of stem cell compartment has been speculated in mouse hematopoietic and embryonic systems. We have consistently observed an increase in apoptosis in the cord blood derived CD34+ cells cultured with cytokines compared to their freshly isolated counterpart. The present study was undertaken to assess whether pharmacological inhibition of apoptosis could improve the outcome of expansion.
机译:背景脐血(CB)是造血干细胞移植的有希望的来源。与这种来源相关的细胞剂量的限制已经促使造血干细胞和祖细胞(HSPCs)的离体扩增。但是,已知扩增程序会耗尽干细胞库,从而导致细胞缺陷,从而促进细胞凋亡并破坏骨髓的归巢。已经在小鼠造血和胚胎系统中推测了凋亡机制在干细胞区室调节中的作用。我们一直观察到,与新鲜分离的对应物相比,用细胞因子培养的脐血CD34 + 细胞的凋亡增加。进行本研究以评估药理作用对细胞凋亡的抑制是否可以改善扩张的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号